Delivery Order SPE2DB22D1002-SPE2DB24FKXB9
Award Date 1/26/24
Potential Completion Date 1/29/24
Potential Value $2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $11,636.87 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VRAYLAR 1.5 MG CAPSULE 30S. This contract, with a completion date of March 6, 2024, is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $5,313.66 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4563588342 - VRAYLAR 6 MG CAPSULE 30S. This delivery order contract has a completion date of February 8, 2024 and was awarded on February 7, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,259,825 units of the pharmaceutical product VRAYLAR 1.5 MG CAPSULE 30S. The contract has a ceiling value of $5,226.62 and a completion date of April 15, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used. This delivery order is part of a larger indefinite delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,568.07 to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The contract is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, with a completion date of January 5, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor. This delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $36,817.54 to AmerisourceBergen Drug Corp for the supply of VRAYLAR 1.5 MG CAPSULE 30S. This order was placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through December 2025. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical medical commodities to support military treatment...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $10,793.07 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of VRAYLAR 1.5 MG CAPSULE 30S. This order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,644.85 firm-fixed-price delivery order is for the supply of VRAYLAR 3 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of May 30, 2024 and was awarded on May 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,358.30 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VRAYLAR 3 MG CAPSULE 30S. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally....
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $7,582.61 to AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. The contract is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. This delivery order contract falls under a larger indefinite delivery contract (IDC) previously awarded to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $7,801.34, is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, with a completion date of March 8, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime...